相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Novel strategies targeting bromodomain-containing protein 4 (BRD4) for cancer drug discovery
Dailin Liang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2020)
Androgen receptor degraders over come common resistance mechanisms developed during prostate cancer treatment
Steven Kregel et al.
NEOPLASIA (2020)
Inhibitor of Apoptosis Protein (IAP) Antagonists in Anticancer Agent Discovery: Current Status and Perspectives
Hui Cong et al.
JOURNAL OF MEDICINAL CHEMISTRY (2019)
Degradation of Bruton's tyrosine kinase mutants by PROTACs for potential treatment of ibrutinib-resistant non-Hodgkin lymphomas
Yonghui Sun et al.
LEUKEMIA (2019)
Proteolysis targeting chimeras (PROTACs) in 'beyond rule-of-five' chemical space: Recent progress and future challenges
Scott D. Edmondson et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2019)
Targeting BCR-ABL1 in Chronic Myeloid Leukemia by PROTAC-Mediated Targeted Protein Degradation
George M. Burslem et al.
CANCER RESEARCH (2019)
Targeted protein degradation: expanding the toolbox
Matthieu Schapira et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
ARV-471, an oral estrogen receptor PROTAC degrader for breast cancer
J. J. Flanagan et al.
CANCER RESEARCH (2019)
Development of Protein Degradation Inducers of Androgen Receptor by Conjugation of Androgen Receptor Ligands and Inhibitor of Apoptosis Protein Ligands
Norihito Shibata et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
Targeting the C481S Ibrutinib-Resistance Mutation in Bruton's Tyrosine Kinase Using PROTAC-Mediated Degradation
Alexandru D. Buhimschi et al.
BIOCHEMISTRY (2018)
Derivatization of inhibitor of apoptosis protein (IAP) ligands yields improved inducers of estrogen receptor degradation
Nobumichi Ohoka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2018)
Androgen receptor degradation by the proteolysis-targeting chimera ARCC-4 outperforms enzalutamide in cellular models of prostate cancer drug resistance
Jemilat Salami et al.
COMMUNICATIONS BIOLOGY (2018)
In Vivo Knockdown of Pathogenic Proteins via Specific and Nongenetic Inhibitor of Apoptosis Protein (IAP)-dependent Protein Erasers (SNIPERs)
Nobumichi Ohoka et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2017)
Targeting the Allosteric Site of Oncoprotein BCR-ABL as an Alternative Strategy for Effective Target Protein Degradation
Kenichiro Shimokawa et al.
ACS MEDICINAL CHEMISTRY LETTERS (2017)
Development of a peptide-based inducer of protein degradation targeting NOTCH1
Nobumichi Ohoka et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2017)
Development of protein degradation inducers of oncogenic BCR-ABL protein by conjugation of ABL kinase inhibitors and IAP ligands
Norihito Shibata et al.
CANCER SCIENCE (2017)
Discovery of Small Molecules that Induce the Degradation of Huntingtin
Shusuke Tomoshige et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2017)
Modular PROTAC Design for the Degradation of Oncogenic BCR-ABL
Ashton C. Lai et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Small-Molecule PROTACS: New Approaches to Protein Degradation
Momar Toure et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2016)
Development of a peptide-based inducer of nuclear receptors degradation
Yosuke Demizu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Development of BCR-ABL degradation inducers via the conjugation of an imatinib derivative and a cIAP1 ligand
Yosuke Demizu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2016)
Small molecules, big targets: drug discovery faces the protein-protein interaction challenge
Duncan E. Scott et al.
NATURE REVIEWS DRUG DISCOVERY (2016)
PROTAC-induced BET protein degradation as a therapy for castration-resistant prostate cancer
Kanak Raina et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
HaloPROTACS: Use of Small Molecule PROTACs to Induce Degradation of Halo Tag Fusion Proteins
Dennis L. Buckley et al.
ACS CHEMICAL BIOLOGY (2015)
Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4
Michael Zengerle et al.
ACS CHEMICAL BIOLOGY (2015)
Targeting Cullin-RING E3 ubiquitin ligases for drug discovery: structure, assembly and small-molecule modulation
Emil Bulatov et al.
BIOCHEMICAL JOURNAL (2015)
Targeting the ubiquitin pathway for cancer treatment
Jia Liu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2015)
Hijacking the E3 Ubiquitin Ligase Cereblon to Efficiently Target BRD4
Jing Lu et al.
CHEMISTRY & BIOLOGY (2015)
Catalytic in vivo protein knockdown by small-molecule PROTACs
Daniel P. Bondeson et al.
NATURE CHEMICAL BIOLOGY (2015)
Phthalimide conjugation as a strategy for in vivo target protein degradation
Georg E. Winter et al.
SCIENCE (2015)
Small-Molecule Control of Intracellular Protein Levels through Modulation of the Ubiquitin Proteasome System
Dennis L. Buckley et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Privileged Structures: Efficient Chemical Navigators toward Unexplored Biologically Relevant Chemical Spaces
Jonghoon Kim et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2014)
Small-molecule SMAC mimetics as new cancer therapeutics
Longchuan Bai et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Cancer cell death induced by novel small molecules degrading the TACC3 protein via the ubiquitin-proteasome pathway
N. Ohoka et al.
CELL DEATH & DISEASE (2014)
Development of hybrid small molecules that induce degradation of estrogen receptor-alpha and necrotic cell death in breast cancer cells
Keiichiro Okuhira et al.
CANCER SCIENCE (2013)
Design and synthesis of estrogen receptor degradation inducer based on a protein knockdown strategy
Yosuke Demizu et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Double protein knockdown of cIAP1 and CRABP-II using a hybrid molecule consisting of ATRA and IAPs antagonist
Yukihiro Itoh et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2012)
Development of target protein-selective degradation inducer for protein knockdown
Yukihiro Itoh et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Design, synthesis and biological evaluation of nuclear receptor-degradation inducers
Yukihiro Itoh et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2011)
Nuclear Receptors in Liver Disease
Martin Wagner et al.
HEPATOLOGY (2011)
Nuclear receptors as drug targets for metabolic disease
Ira G. Schulman
ADVANCED DRUG DELIVERY REVIEWS (2010)
Chemical Inducers of Targeted Protein Degradation
Kanak Raina et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Protein Knockdown Using Methyl Bestatin-Ligand Hybrid Molecules: Design and Synthesis of Inducers of Ubiquitination-Mediated Degradation of Cellular Retinoic Acid-Binding Proteins
Yukihiro Itoh et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2010)
siRNA applications in nanomedicine
Talar Tokatlian et al.
WILEY INTERDISCIPLINARY REVIEWS-NANOMEDICINE AND NANOBIOTECHNOLOGY (2010)
Targeting inhibitor of apoptosis proteins for therapeutic intervention
Chudi Ndubaku et al.
FUTURE MEDICINAL CHEMISTRY (2009)
Direct inhibition of the NOTCH transcription factor complex
Raymond E. Moellering et al.
NATURE (2009)
Targeted intracellular protein degradation induced by a small molecule: En route to chemical proteomics
Ashley R. Schneekloth et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2008)
Small molecules destabilize cIAP1 by activating auto-ubiquitylation
Keiko Sekine et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Development of an aryl hydrocarbon receptor antagonist using the proteolysis-targeting chimeric molecules approach: A potential tool for chemoprevention
Dinesh Puppala et al.
MOLECULAR PHARMACOLOGY (2008)
IAPs contain an evolutionarily conserved ubiquitin-binding domain that regulates NF-κB as well as cell survival and oncogenesis
Mads Gyrd-Hansen et al.
NATURE CELL BIOLOGY (2008)
Overcoming retinoic acid-resistance of mammary carcinomas by diverting retinoic acid from PPARβ/δ to RAR
Thaddeus T. Schug et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Reaching for high-hanging fruit in drug discovery at protein-protein interfaces
James A. Wells et al.
NATURE (2007)
Opposing effects of retinoic acid on cell growth result from alternate activation of two different nuclear receptors
Thaddeus T. Schug et al.
CELL (2007)
Human inhibitor of apoptosis proteins: why XIAP is the black sheep of the family
Brendan P. Eckelman et al.
EMBO REPORTS (2006)
The inhibitor of apoptosis protein fusion c-IAP2•MALT1 stimulates NF-κB activation independently of TRAF1 AND TRAF2
Eugene Varfolomeev et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The human anti-apoptotic proteins cIAP1 and cIAP2 bind but do not inhibit caspases
BP Eckelman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Distinct BIR domains of cIAP1 mediate binding to and ubiquitination of tumor necrosis factor receptor-associated factor 2 and second mitochondrial activator of caspases
T Samuel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
A small molecule Smac mimic potentiates TRAIL- and TNFα-mediated cell death
L Li et al.
SCIENCE (2004)
Increases in estrogen receptor-alpha concentration in breast cancer cells promote serine 118/104/106-independent AF-1 transactivation and growth in the absence of estrogen
AM Fowler et al.
FASEB JOURNAL (2004)
A role for NF-κB essential modifier/IκB kinase-γ (NEMO/IKKγ) ubiquitination in the activation of the IκB kinase complex by tumor necrosis factor-α
ED Tang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Development of protacs to target cancer-promoting proteins for ubiquitination and degradation
KM Sakamoto et al.
MOLECULAR & CELLULAR PROTEOMICS (2003)
IAP proteins: Blocking the road to death's door
GS Salvesen et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Direct channeling of retinoic acid between cellular retinoic acid-binding protein II and retinoic acid receptor sensitizes mammary carcinoma cells to retinoic acid-induced growth arrest
AS Budhu et al.
MOLECULAR AND CELLULAR BIOLOGY (2002)
Protacs: Chimeric molecules that target proteins to the Skp1-Cullin-F box complex for ubiquitination and degradation
KM Sakamoto et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
XIAP: Apoptotic brake and promising therapeutic target
M Holcik et al.
APOPTOSIS (2001)
分享论文
